Fcpm Iii Services B.V.
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$722.2M
Q ending 2026-03-31
Prior quarter
$762.9M
Q ending 2025-12-31
Change
-5.3% QoQ · +74.6% YoY
Positions
10
reported holdings
Largest positions
All 10 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Newamsterdam Pharma Company | Shares | $294.5M | 9.2M | |
| Dyne Therapeutics Inc | DYN | Shares | $84.2M | 4.6M |
| Vor Biopharma Inc | VOR | Shares | $73.5M | 4.1M |
| Engene Holdings Inc | Shares | $65.6M | 9.6M | |
| Maplight Therapeutics Inc | MPLT | Shares | $65.6M | 3.2M |
| Damora Therapeutics Inc | DMRA | Shares | $63.2M | 2.4M |
| Crescent Biopharma Inc. | Shares | $30.8M | 1.7M | |
| Replimune Group Inc | REPL | Shares | $21.5M | 2.8M |
| Bicycle Therapeutics Plc | BCYC | Shares | $16.1M | 3.5M |
| Engene Holdings Inc | Shares | $7.3M | 2.9M |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.